Sodium/iodide symporter expression in primary lung cancer and comparison with glucose transporter 1 expression

Pathology International

Volumn 59, Issue 2, 2009, Pages 73-79

  Kang, Do Y ^a   Lee, Hyoun W ^a   Choi, Phil J ^a   Lee, Kyung E ^a   Roh, Mee S ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Glucose transporter 1; Immunohistochemistry; Lung cancer; Sodium iodide symporter

Indexed keywords

GLUCOSE TRANSPORTER 1; SODIUM IODIDE SYMPORTER; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SMALL CELL LUNG CARCINOMA; SYMPORTERS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149277044     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02331.x     Document Type: Article

References (21)

1. Dai G, Levy O, Carasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996 379 : 458 60.
2. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999 141 : 443 57.
3. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001 84 : 499 503.
4. Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab 1998 83 : 1746 51.
5. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab 1999 84 : 4178 84.
6. Spitzweg C, Dutton CM, Castro MR et al. Expression of the sodium iodide symporter in human kidney. Kidney Int 2001 59 : 1013 23.
7. Tazebay UH, Wapnir IL, Levy O et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000 6 : 871 8.
8. Haberkorn U. Gene therapy with sodium/iodide symporter in hepatocarcinoma. Exp Clin Endocrinol Diabetes 2001 109 : 60 62.
9. Spitzweg C, Morris JC. Approaches to gene therapy with sodium iodide symporter. Exp Clin Endocrinol Diabetes 2001 109 : 56 9.
10. Groot-Wassink T, Aboagye EO, Glaser M, Lemoine NR, Vassaux G. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002 13 : 1723 35.
11. Hoh CK, Schiepers C, Seltzer MA et al. PET in oncology: Will it replace the other modalities? Semin Nucl Med 1997 27 : 94 106.
12. 18F] FDG uptake in non-small cell lung cancer. Eur J Nucl Med 2000 27 : 1778 85.
13. Ito T, Noguchi Y, Satoh S, Hayashi H, Inayama Y, Kitamura H. Expression of facilitative glucose transporter isoforms in lung carcinomas: Its relation to histologic type, differentiation grade, and tumor stage. Mod Pathol 1998 11 : 437 43.
14. Wong CY, Nunez R, Bohdiewicz P et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. Eur J Nucl Med 2001 28 : 1702 5.
15. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization Classification of Tumour. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon : IARC Press, 2004.
16. Mountain CF. Revisions in the international staging for lung cancer. Chest 1997 111 : 1711 17.
17. Lee KE, Kang DY, Choi PJ et al. Immunohistochemical expressions of sodium/iodide symporter (NIS) and thyroid transcription factor-1 (TTF-1) and their relationship in primary pulmonary adenocarcinoma. J Exp Biomed Sci 2006 12 : 171 6.
18. 131I uptake in recurrent lesions of differentiated thyroid carcinoma. Eur J Nucl Med 2001 28 : 639 45.
19. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: Correlation with radioiodine uptake. J Clin Endocrinol Metab 2001 86 : 5627 32.
20. Dingli D, Kemp BJ, O'Conner MK, Morrise JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006 8 : 16 23.
21. Wapnir IL, van de Rijn M, Nowels K et al. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 2003 88 : 1880 88.